+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Remote Patient Monitoring Devices In North America

  • PDF Icon

    Report

  • 50 Pages
  • April 2025
  • Region: North America
  • GlobalData
  • ID: 6145260
Remote Patient Monitoring Devices in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • Remote patient monitoring (RPM) involves the utilization of digital technologies and services to oversee, analyze, and capture patients' health data, which is subsequently transmitted to healthcare professionals for thorough assessment. Market scope excludes glucose monitoring devices and neurological monitors.
  • The North American remote patient monitoring devices market recorded revenues of $1.24 billion in 2024, representing a compound annual growth rate (CAGR) of 4.7% between 2019 and 2024.
  • The external remote patient monitoring devices segment accounted for the market's largest proportion in 2024, with total revenues of $666 million, equivalent to 53.6% of the market's overall value.
  • In 2024, the US accounted for a share of 89.7% of the North American remote patient monitoring devices market, making it the largest market in the region.

Scope

  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the remote patient monitoring devices market in North America
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the remote patient monitoring devices market in North America
  • Leading company profiles reveal details of key remote patient monitoring devices market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the North America remote patient monitoring devices market with five year forecasts

Reasons to Buy

  • What was the size of the North America remote patient monitoring devices market by value in 2024?
  • What will be the size of the North America remote patient monitoring devices market in 2029?
  • What factors are affecting the strength of competition in the North America remote patient monitoring devices market?
  • How has the market performed over the last five years?
  • What are the main segments that make up North America's remote patient monitoring devices market?

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the key market players?
7.2. What strategies do the key players follow?
7.3. What are the strengths of the key players?
7.4. What are the recent market developments?
8 Company Profiles
8.1. Abbott Laboratories
8.2. Medtronic Plc
8.3. Boston Scientific Corp
8.4. DexCom Inc
8.5. VivaLNK Inc
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related the analyst research
10.4. About the Analyst
List of Tables
Table 1: North America remote patient monitoring devices market value: $ million, 2019-24
Table 2: North America remote patient monitoring devices market category segmentation: % share, by value, 2019-24
Table 3: North America remote patient monitoring devices market category segmentation: $ million, 2019-24
Table 4: North America remote patient monitoring devices market geography segmentation: $ million, 2024
Table 5: North America remote patient monitoring devices market value forecast: $ million, 2024-29
Table 6: Abbott Laboratories: Key Facts
Table 7: Abbott Laboratories: annual financial ratios
Table 8: Abbott Laboratories: key employees
Table 9: Abbott Laboratories: key employees Continued
Table 10: Medtronic Plc: Key Facts
Table 11: Medtronic Plc: annual financial ratios
Table 12: Medtronic Plc: key employees
Table 13: Boston Scientific Corp: Key Facts
Table 14: Boston Scientific Corp: annual financial ratios
Table 15: Boston Scientific Corp: key employees
Table 16: Boston Scientific Corp: key employees Continued
Table 17: DexCom Inc: Key Facts
Table 18: DexCom Inc: annual financial ratios
Table 19: DexCom Inc: key employees
Table 20: VivaLNK Inc: Key Facts
Table 21: VivaLNK Inc: key employees
Table 22: North America Exchange Rate, 2019-24
List of Figures
Figure 1: North America remote patient monitoring devices market value: $ million, 2019-24
Figure 2: North America remote patient monitoring devices market category segmentation: $ million, 2019-24
Figure 3: North America remote patient monitoring devices market geography segmentation: % share, by value, 2024
Figure 4: North America remote patient monitoring devices market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the remote patient monitoring devices market in North America, 2024
Figure 6: Drivers of buyer power in the remote patient monitoring devices market in North America, 2024
Figure 7: Drivers of supplier power in the remote patient monitoring devices market in North America, 2024
Figure 8: Factors influencing the likelihood of new entrants in the remote patient monitoring devices market in North America, 2024
Figure 9: Factors influencing the threat of substitutes in the remote patient monitoring devices market in North America, 2024
Figure 10: Drivers of degree of rivalry in the remote patient monitoring devices market in North America, 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • DexCom Inc
  • VivaLNK Inc